Biotech News

The neoantigen targeted therapies market is projected to grow at an annualized rate of 57%, till 2030

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

January 25, 2021

The neoantigen targeted therapies market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis

An in-depth analysis of the various patents that have been filed / granted related to neoantigens.

January 25, 2021

Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, growing at an annualized rate of 57%, claims Roots Analysis

n fact, more than 6,000 patents were filed / granted related to neoantigen targeted therapies, since 1978.

January 25, 2021

The ‘Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030’

 A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing regulatory affairs management services to medical device developers

January 25, 2021

Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services

More than 130 medical devices were approved by the FDA since January 2018

January 25, 2021

Immunoglobulin Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2027 | Baxter international Inc., CSL Ltd.

Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition.

January 25, 2021

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030,

The market landscape is highly fragmented, featuring the presence of both established players and new entrants; majority of such firms are located in the developed geographies

January 25, 2021

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

January 25, 2021

Healthcare Analytics Market: Current Analysis and Forecast (2020-2027)

Healthcare Analytics Market is expected to foresee significant growth during the forecast. North America to witness the highest growth

January 22, 2021

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis

Despite mammalian cell cultures being the preferred manufacturing approach for biologics

January 21, 2021

Ingestible Smart Pills Market Size By Analysis, Key Vendors, Regions, Type and Application, and Forecasts to 2027

Smart pills can be used to monitor drug adherence, temperature and some other parameters in patients. These pills are ingestible medical devices that can be taken orally to examine the gastrointestinal tract (GI).

January 18, 2021

The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules

A detailed review of the overall landscape of companies offering in silico drug discovery services for large molecules

January 15, 2021

Over 90 firms are actively involved in providing in silico services for drug discovery of different types of biologics

Presently, in silico tools / approaches are available for the identification

January 15, 2021

In silico drug discovery services market is likely to be worth USD 124 million by 2030

Majority of the companies offer structure-based drug design focused on early stage drug discovery of a range of large molecules, including antibodies, proteins and peptides

January 15, 2021

In silico drug discovery services market is likely to be worth USD 124 million by 2030

A detailed assessment of the current market landscape of companies offering in silico drug discovery services for large molecules.

January 15, 2021

The “Global Handheld Ultrasound Imaging Devices Market, 2020-2030”

A detailed brand positioning analysis of key industry players, highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects

January 15, 2021

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Over 150 software solutions are currently available for use in drug discovery

January 15, 2021

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

January 15, 2021

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030

Around 100 handheld ultrasound imaging devices, incorporating different transducer arrays and advanced software, are being actively used by physicians to scan different body parts.

January 15, 2021

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030

A detailed assessment of the current market landscape of companies engaged in the development / manufacturing of handheld ultrasound imaging devices

January 15, 2021

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

January 15, 2021

The ‘‘Microbial Contract Biomanufacturing Market, 2020-2030’’

A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.

January 14, 2021

Over 115 companies, across the world, claim to offer a variety of product development

Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various aspects of their respective microbial biologic development programs.

January 14, 2021

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030

The market features the presence of several well-established players across the globe

January 14, 2021

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts Roots Analysis

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

January 14, 2021

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment

January 14, 2021

The “In Vitro ADME Testing Services Market, 2019-2030”

A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018

January 14, 2021

Over 90 firms are actively involved in providing in vitro ADME testing services; of these,

Currently, there are a number of contract research organizations (CROs) that claim to have the necessary capabilities to offer in vitro ADME services.

January 14, 2021

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%

Several players involved in this domain are steadily expanding their capabilities in order to enhance their respective in the in vitro

January 14, 2021

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030,

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME)

January 14, 2021

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis

Nearly 60% of these companies are small and mid-sized firms. Further, close to 35% of the CROs engaged in this domain, claim to provide services to both pharmaceutical companies and academic institutes.

January 14, 2021

‘Human Microbiome Market: Focus on Therapeutics (including gut-brain axis targeting drugs),

A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework

January 13, 2021

Presently, 260 drug candidates are being evaluated in clinical

Despite having captured the interest of several venture capital firms and big pharma players

January 13, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030,

Prevalent trends indicate that microbiome drugs and diagnostics market is poised to grow significantly

January 13, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030

An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.

January 13, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030,

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community

January 13, 2021

The “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution)

An informative analysis of contemporary Google Trends in the time period between 2015 and 2020 (till July) and insights from the recent news articles related digital therapeutic solutions, indicating the increasing popularity of this domain.

January 13, 2021

Over 100 industry players are engaged in evaluating the potential of several prescription

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.

January 13, 2021

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis

The projected market opportunity is anticipated to be well-distributed across different therapeutic areas, distribution channels and key geographical regions

January 13, 2021

The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030, predicts Roots Analysis

Elaborate profiles of key industry players that offer a several digital therapeutic solutions (shortlisted on the basis of the product portfolio).

January 13, 2021

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis

The market in Asia-Pacific regions is anticipated to grow at a relatively faster pace (23.2%). In 2030,

January 13, 2021

News by Category: Biotech